Access brought to you by: LOCKSS

Cardiology & Cardiovascular Medicine

Tryton Two-Stent Strategy Safe, but Did Not Meet Noninferiority Endpoint
EU-PACT Study: Initial Warfarin Dosing Improved by Clinical Variables and Genotype to Guide Therapy
No Change in Thrombotic Risk with Short-Term DAPT after Stenting
COAG Trial: No Advantage Seen with Genetic-Based Warfarin Dosing
Prolonged DAPT is Unnecessary Post-Stenting in Patients Who are Event-Free at 1 Year
No Benefit to Renal Artery Stenting Seen in CORAL Trial
Risk of Major Cardiovascular or Cerebrovascular Events after PCI or CABG Increased in Diabetes Mellitus Patients Receiving Insulin
Immediate Targeted Blood Pressure Reduction Does Not Improve Outcomes in Acute Stroke
Thrombectomy Does Not Prevent Microvascular Obstruction in Patients Undergoing PCI for NSTEMI
Guidelines for Prevention of Atherosclerotic Cardiovascular Disease

Pages